TY - JOUR
T1 - Serum lipids in Norplant® implants users
T2 - A cross-sectional study
AU - Affandi, Biran
AU - Suherman, Suharti K
AU - Djajalelana,
AU - Prihartono, Joedo
AU - Lubis, F.
AU - Samil, R. S.
PY - 1987/1/1
Y1 - 1987/1/1
N2 - One of the methods to establish the safety and risk profile of hormonal contraceptives is employing a study on their metabolic effects. In order to evaluate the effect of Norplant® implants on serum lipids, a cross-sectional study was undertaken at Klinik Raden Saleh, Jakarta. The subjects recruited were divided into 8 groups depending on the length of Norplant® use, i.e. before insertion, 6 months, 12 months, 24 months, 36 months, 48 months, 60 months and one week after the removal of Norplant®. Blood samples were collected from the subjects after an overnight fast. The parameters studied were triglycerides, total cholesterol, HDL-cholesterol and LDL-cholesterol. There were no significant differences between the groups regarding the triglycerides and HDL-cholesterol (p > 0.05). There were significant differences between the groups regarding the total cholesterol and LDL-cholesterol (p < 0.01).
AB - One of the methods to establish the safety and risk profile of hormonal contraceptives is employing a study on their metabolic effects. In order to evaluate the effect of Norplant® implants on serum lipids, a cross-sectional study was undertaken at Klinik Raden Saleh, Jakarta. The subjects recruited were divided into 8 groups depending on the length of Norplant® use, i.e. before insertion, 6 months, 12 months, 24 months, 36 months, 48 months, 60 months and one week after the removal of Norplant®. Blood samples were collected from the subjects after an overnight fast. The parameters studied were triglycerides, total cholesterol, HDL-cholesterol and LDL-cholesterol. There were no significant differences between the groups regarding the triglycerides and HDL-cholesterol (p > 0.05). There were significant differences between the groups regarding the total cholesterol and LDL-cholesterol (p < 0.01).
UR - http://www.scopus.com/inward/record.url?scp=0023554973&partnerID=8YFLogxK
U2 - 10.1016/0010-7824(87)90091-6
DO - 10.1016/0010-7824(87)90091-6
M3 - Article
C2 - 3127112
AN - SCOPUS:0023554973
VL - 36
SP - 429
EP - 434
JO - Contraception
JF - Contraception
SN - 0010-7824
IS - 4
ER -